Enzyme-Responsive Nanoparticles for Targeted Accumulation and Prolonged Retention in Heart Tissue after Myocardial Infarction - Wikidata - wikimedia - TriplyDB

Enzyme-Responsive Nanoparticles for Targeted Accumulation and Prolonged Retention in Heart Tissue after Myocardial Infarction

Enzyme-Responsive Nanoparticles for Targeted Accumulation and Prolonged Retention in Heart Tissue after Myocardial Infarction

http://www.wikidata.org/entity/Q41295473

about

The Smart Drug Delivery System and Its Clinical Potential Biosynthetic Polymers as Functional Materials Targeted Delivery Systems for Molecular Therapy in Skeletal Disorders Fluorocoxib A loaded nanoparticles enable targeted visualization of cyclooxygenase-2 in inflammation and cancer Dual-responsive nanoparticles release cargo upon exposure to matrix metalloproteinase and reactive oxygen species.Ventricular wall biomaterial injection therapy after myocardial infarction: Advances in material design, mechanistic insight and early clinical experiences.Vascular-targeted nanocarriers: design considerations and strategies for successful treatment of atherosclerosis and other vascular diseases.New perspectives in nanotherapeutics for chronic respiratory diseases.Polycatechol Nanoparticle MRI Contrast Agents.Enzyme-Responsive Nanoparticles for the Treatment of Disease.Enzyme-regulated topology of a cyclic peptide brush polymer for tuning assembly.Enzyme-Targeted Nanoparticles for Delivery to Ischemic Skeletal Muscle.Rotaxane probes for protease detection by 129Xe hyperCEST NMR.Self-assembly of peptide amphiphiles for drug delivery: the role of peptide primary and secondary structures.Mechanisms that determine nanocarrier targeting to healthy versus inflamed lung regions.Biomimicking Platelet-Monocyte Interactions as a Novel Targeting Strategy for Heart Healing.Targeting regenerative exosomes to myocardial infarction using cardiac homing peptide.Endogenous pH-responsive nanoparticles with programmable size changes for targeted tumor therapy and imaging applications.Morphology transformation of self-assembled organic nanomaterials in aqueous solution induced by stimuli-triggered chemical structure changes

P2860

Q26744837-C7914C7E-CAD7-4C62-97A9-746527D269C1 Q26745443-15F62EE4-8DAD-45B8-AFE0-24597D96ED3B Q26752158-98645F58-CE8F-42B3-9603-70652BBB42B7 Q30743369-A1EF9AE3-E5D1-4E49-8F08-E19C254152C8 Q35876183-8A99D81B-5148-4637-ACC6-39CA51E82DBD Q38742092-E8EEDB23-FBB8-459F-8FFF-5AE972242A5D Q38838043-6AF9892C-3CE9-4652-82B8-A1EFF513518B Q40039105-D61A01DF-9C98-4B51-9701-AB50F7FA675A Q41820535-5841ACFA-D279-42B6-8538-2D9252EB3DEA Q45998817-901CFD7D-4A73-4C5C-858F-3989A4E27438 Q46022391-BBC74031-08A1-4858-AD9B-8168A8D7A7AD Q46269755-007ECA99-3B1C-47D4-9483-B8D34206F4EE Q46628388-0C011F3C-F53A-4D63-90EA-53F8D3612BFB Q47427416-0DB08FE0-A090-4F95-9743-67AD8539FB26 Q48003088-F237184C-F61E-400A-9351-66B3F0E30030 Q48957301-54B2E55D-4BD1-4631-904A-F46EED874AA7 Q52647641-192BB0E2-CD0E-4722-A77F-AEEF83DB0A3A Q55369803-3A3BFBBA-C05F-435A-BBDF-0EB18D80C0D5 Q57377483-03FABEC7-DDD2-4513-9486-BD6E73507ACD

P2860

Enzyme-Responsive Nanoparticles for Targeted Accumulation and Prolonged Retention in Heart Tissue after Myocardial Infarction

http://www.wikidata.org/entity/Q41295473

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Enzyme-Responsive Nanoparticle ...... ue after Myocardial Infarction

@en

type

label

Enzyme-Responsive Nanoparticle ...... ue after Myocardial Infarction

@en

prefLabel

Enzyme-Responsive Nanoparticle ...... ue after Myocardial Infarction

@en

P1433

Q41295473-C07B485A-8383-4521-B019-1B330D472CE5

P1476

Q41295473-D8657921-99EB-4BD4-8F32-0D0D66F66CBF

P2093

Q41295473-1D3A6A03-9D5F-4BF4-A440-B2C2A54EB13B

Q41295473-23ACDCC5-7FDC-478F-9055-8DEF38069E60

Q41295473-3CD00925-C052-46CA-AC69-026DD60DFE4C

Q41295473-69F1D26B-75C3-44C6-A34D-896CDAAC59DF

Q41295473-752DB389-3A6B-44D3-AB76-CF7AE36387BA

Q41295473-AD3AC7DE-C0A6-4F30-BEE7-0E2E2A5CDFED

Q41295473-BC78B501-C95F-4954-928B-AE11D1999FEE

Q41295473-BF3AD356-8F49-4EBF-9005-A19250A3A01D

Q41295473-DA9FB08C-5689-4299-BB9D-3089D3C4583D

Q41295473-F56E5419-33ED-4B04-AA98-54239983EF01

P2860

Q41295473-01D7065E-EA0F-4038-A277-806840235896

Q41295473-0F3280D2-DEFF-4221-BED2-B9DDD29428DD

Q41295473-12A1B2A7-EBA4-4D81-9F43-84CCE639EC86

Q41295473-1CF9CFBE-580D-4B26-B3EB-0098A04ABB3D

Q41295473-2AD80954-13F5-4C32-9D91-93474292BC6D

Q41295473-2F9281F4-BB11-4FAB-A9BA-F398F5044F34

Q41295473-332828A9-2DB4-4AA7-B124-19D12A2C921F

Q41295473-378BEE5B-63AE-4279-B90F-2D3CB825F451

Q41295473-3D4E2C02-01CB-4E7D-81B8-391DF13BB770

Q41295473-3DCE9795-0AF6-41F2-A1E4-2AC9FA6BC2C7

P304

Q41295473-1C8CD3DF-C3A7-431D-B26A-ECCB07E991AF

P31

Q41295473-C4C8E027-C827-4D93-B2AD-57DAFCB71156

P356

Q41295473-B4B6C394-B279-4223-B46D-F0F292A5E1D7

P407

Q41295473-9DA9EC9C-8428-49A2-BFF0-A36AEA2079D2

P433

Q41295473-C8C7BD52-5E6D-49FB-BD03-21C190C7BA26

P478

Q41295473-AFD57656-9D82-40DA-86E5-947CB71713B8

P577

Q41295473-557D1B80-F3AA-408A-8C1D-68EED0245E84

P698

Q41295473-B86E9ADE-EB70-4CEF-BDB8-E983C427839E

P921

Q41295473-7A74EFA3-C64B-4256-9A53-2AA78F928A6E

P932

Q41295473-5EEDE4E4-2C82-46D0-965E-848E3260B963

P356

P1433

Advanced Materials

P1476

Enzyme-Responsive Nanoparticle ...... ue after Myocardial Infarction

@en

P2093

Andrea S Carlini

http://www.w3.org/2001/XMLSchema#string

Colin Luo

http://www.w3.org/2001/XMLSchema#string

Karen L Christman

http://www.w3.org/2001/XMLSchema#string

Kent G Osborn

http://www.w3.org/2001/XMLSchema#string

Mary M Nguyen

http://www.w3.org/2001/XMLSchema#string

Miao-Ping Chien

http://www.w3.org/2001/XMLSchema#string

Nathan C Gianneschi

http://www.w3.org/2001/XMLSchema#string

Rebecca L Braden

http://www.w3.org/2001/XMLSchema#string

Sonya Sonnenberg

http://www.w3.org/2001/XMLSchema#string

Yiwen Li

http://www.w3.org/2001/XMLSchema#string

P2860

Heart Disease and Stroke Statistics--2015 Update: A Report From the American Heart Association

Renal clearance of quantum dots.

Targeted delivery of antibody conjugated liposomal drug carriers to rat myocardial infarction

Enzyme-directed assembly of nanoparticles in tumors monitored by in vivo whole animal imaging and ex vivo super-resolution fluorescence imaging

Mechanisms and models in heart failure: A combinatorial approach.

Infarct scar: a dynamic tissue.

Enzyme-directed assembly of a nanoparticle probe in tumor tissue

A review of the in vivo and in vitro toxicity of silver and gold particulates: particle attributes and biological mechanisms responsible for the observed toxicity.

Concise review: injectable biomaterials for the treatment of myocardial infarction and peripheral artery disease: translational challenges and progress.

Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology

P304

5547-5552

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ADMA.201502003

http://www.w3.org/2001/XMLSchema#string

P407

P433

37

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26305446

http://www.w3.org/2001/XMLSchema#string

P921

P932

4699559

http://www.w3.org/2001/XMLSchema#string